Literature DB >> 21806988

Phospholipid scramblase 1 mediates hepatitis C virus entry into host cells.

Qiaoling Gong1, Min Cheng, Hui Chen, Xiuying Liu, Youhui Si, Yang Yang, Yanzhi Yuan, Chaozhi Jin, Wei Yang, Fuchu He, Jian Wang.   

Abstract

Hepatitis C virus (HCV) infects human hepatocytes through several host factors. However, other prerequisite factors for viral entry remain to be identified. Using a yeast two-hybrid screen, we found that human phospholipid scramblase 1 interacts with HCV envelope proteins E1 and E2. These physical interactions were confirmed by co-immunoprecipitation and GST pull-down assays. Knocking down the expression of PLSCR1 inhibited the entry of HCV pseudoparticles. Moreover, PLSCR1 was required for the initial attachment of HCV onto hepatoma cells, where it specifically interacted with entry factor OCLN. We show that PLSCR1 is a novel attachment factor for HCV entry.
Copyright © 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21806988     DOI: 10.1016/j.febslet.2011.07.019

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  Proteomic analysis of membrane proteins of vero cells: exploration of potential proteins responsible for virus entry.

Authors:  Donghua Guo; Qinghe Zhu; Hong Zhang; Dongbo Sun
Journal:  DNA Cell Biol       Date:  2013-11-28       Impact factor: 3.311

2.  The missing pieces of the HCV entry puzzle.

Authors:  Sarah C Ogden; Hengli Tang
Journal:  Future Virol       Date:  2015       Impact factor: 1.831

3.  Biophysical characterization of the DNA binding motif of human phospholipid scramblase 1.

Authors:  Sarika Rayala; Ulaganathan Sivagnanam; Sathyanarayana N Gummadi
Journal:  Eur Biophys J       Date:  2022-10-19       Impact factor: 2.095

4.  Differentially regulated gene expression associated with hepatitis C virus clearance.

Authors:  Carolyn Z Grimes; Lu-Yu Hwang; Peng Wei; Dimpy P Shah; Kelly A Volcik; Eric L Brown
Journal:  J Gen Virol       Date:  2012-11-14       Impact factor: 3.891

5.  Cell death-inducing DFFA-like effector b is required for hepatitis C virus entry into hepatocytes.

Authors:  Xianfang Wu; Emily M Lee; Christy Hammack; Jason M Robotham; Mausumi Basu; Jianshe Lang; Margo A Brinton; Hengli Tang
Journal:  J Virol       Date:  2014-05-14       Impact factor: 5.103

6.  Phospholipid scramblase 1 interacts with influenza A virus NP, impairing its nuclear import and thereby suppressing virus replication.

Authors:  Weiyu Luo; Jie Zhang; Libin Liang; Guangwen Wang; Qibing Li; Pengyang Zhu; Yuan Zhou; Junping Li; Yuhui Zhao; Nan Sun; Shanyu Huang; Chenchen Zhou; Yu Chang; Pengfei Cui; Pucheng Chen; Yongping Jiang; Guohua Deng; Zhigao Bu; Chengjun Li; Li Jiang; Hualan Chen
Journal:  PLoS Pathog       Date:  2018-01-19       Impact factor: 6.823

7.  Transcriptional profiling reveals potential involvement of microvillous TRPM5-expressing cells in viral infection of the olfactory epithelium.

Authors:  B Dnate' Baxter; Eric D Larson; Laetitia Merle; Paul Feinstein; Arianna Gentile Polese; Andrew N Bubak; Christy S Niemeyer; James Hassell; Doug Shepherd; Vijay R Ramakrishnan; Maria A Nagel; Diego Restrepo
Journal:  BMC Genomics       Date:  2021-03-30       Impact factor: 3.969

8.  Plasmodium sporozoite phospholipid scramblase interacts with mammalian carbamoyl-phosphate synthetase 1 to infect hepatocytes.

Authors:  Sung-Jae Cha; Min-Sik Kim; Chan Hyun Na; Marcelo Jacobs-Lorena
Journal:  Nat Commun       Date:  2021-11-19       Impact factor: 14.919

9.  The Interferon-Inducible Human PLSCR1 Protein Is a Restriction Factor of Human Cytomegalovirus.

Authors:  Hidetaka Sadanari; Shuichi Kusano; Masaya Takemoto; Tomoki Ishida; Hikaru Otagiri; Tohru Daikoku; Tsugiya Murayama
Journal:  Microbiol Spectr       Date:  2022-02-09

10.  Phospholipid Scramblase 1 Modulates FcR-Mediated Phagocytosis in Differentiated Macrophages.

Authors:  Cecile Herate; Ghania Ramdani; Nancy J Grant; Sabrina Marion; Stephane Gasman; Florence Niedergang; Serge Benichou; Jerome Bouchet
Journal:  PLoS One       Date:  2016-01-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.